Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol Effect on Amygdala Activation in PTSD (VIVITRAU)
NCT01239173Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2010; status: terminated.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01239173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239173.